GSK3368715 dihydrochloride

Overview

GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) is an orally active, reversible, and S-adenosyl-L-methionine (SAM) uncompetitive type I protein arginine methyltransferases (PRMTs) inhibitor ( IC 50 =3.1 nM ( PRMT1 ), 48 nM ( PRMT3 ), 1148 nM ( PRMT4 ), 5.7 nM ( PRMT6 ), 1.7 nM ( PRMT8 )). GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) produces a shift in arginine methylation states, alters exon usage, and has strong anti-cancer activity.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Histone Methyltransferase

Product Information

• Catalog No.: HY-128717A
• CAS No.: 1628925-77-8
• Molecular Formula: C20H40Cl2N4O2
• Molecular Weight: 439.46
• Purity: 99.96%
• Storage: 4°C, stored under nitrogen, away from moisture * In solvent : -80°C, 2 years; -20°C, 1 year (stored under nitrogen, away from moisture)
• Solubility: ≥ 2.08 mg/mL (4.73 mM); Clear solution
• Availability: In-stock

Source

Original product source